ADIPOQ and gestational diabetes: Recently, a meta-analysis that synthesized data from 11 studies comprising 2865 pregnant women showed that circulating adiponectin had a pooled odds ratio of 6.4 (95% CI 4.1, 9.9), a sensitivity of 64.7% (95% CI 51.0%, 76.4%) and a specificity of 77.8% (95% CI 66.4%, 86.1%) for predicting future GDM.